These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 9399128)

  • 1. Excretion of MBDB and BDB in urine, saliva, and sweat following single oral administration.
    Kintz P
    J Anal Toxicol; 1997; 21(7):570-5. PubMed ID: 9399128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of N-methyl-1-(3,4-methylenedioxyphenyl)-2-butanamine (MBDB) in urine from drug users.
    Kronstrand R
    J Anal Toxicol; 1996 Oct; 20(6):512-6. PubMed ID: 8889691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enantiomer analysis of a new street drug, 3,4-methylenedioxy-N-methyl-butanamine, in rat urine.
    Nagai T; Matsushima K; Suzuki A; Saotome A; Kurosu A; Nihei H; Kuroyanagi K; Tokudome S
    J Anal Toxicol; 2002 Mar; 26(2):104-9. PubMed ID: 11916012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of the metabolites of the new designer drugs bk-MBDB and bk-MDEA in human urine.
    Zaitsu K; Katagi M; Kamata HT; Kamata T; Shima N; Miki A; Tsuchihashi H; Mori Y
    Forensic Sci Int; 2009 Jul; 188(1-3):131-9. PubMed ID: 19406592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toxicological detection of the designer drug 3,4-methylenedioxyethylamphetamine (MDE, "Eve") and its metabolites in urine by gas chromatography-mass spectrometry and fluorescence polarization immunoassay.
    Ensslin HK; Kovar KA; Maurer HH
    J Chromatogr B Biomed Appl; 1996 Aug; 683(2):189-97. PubMed ID: 8891915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigations on the human hepatic cytochrome P450 isozymes involved in the metabolism of 3,4-methylenedioxy-amphetamine (MDA) and benzodioxolyl-butanamine (BDB) enantiomers.
    Meyer MR; Peters FT; Maurer HH
    Toxicol Lett; 2009 Oct; 190(1):54-60. PubMed ID: 19576971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytotoxic effects of 3,4-methylenedioxy-N-alkylamphetamines, MDMA and its analogues, on isolated rat hepatocytes.
    Nakagawa Y; Suzuki T; Tayama S; Ishii H; Ogata A
    Arch Toxicol; 2009 Jan; 83(1):69-80. PubMed ID: 18553070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stereoselective differences in the cytochrome P450-dependent dealkylation and demethylenation of N-methyl-benzodioxolyl-butanamine (MBDB, Eden) enantiomers.
    Meyer MR; Peters FT; Maurer HH
    Biochem Pharmacol; 2009 Jun; 77(11):1725-34. PubMed ID: 19428327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of "Ecstasy" components in alternative biological specimens.
    Kintz P; Samyn N
    J Chromatogr B Biomed Sci Appl; 1999 Oct; 733(1-2):137-43. PubMed ID: 10572979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of 2,3- and 3,4-methylenedioxyphenylalkylamines and their regioisomeric differentiation by mass spectral analysis using GC-MS-MS.
    Borth S; Hänsel W; Rösner P; Junge T
    Forensic Sci Int; 2000 Dec; 114(3):139-53. PubMed ID: 11027867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optical isomer analysis of 3,4-methylene-dioxyamphetamine analogues and their stereoselective disposition in rats.
    Matsushima K; Nagai T; Kamiyama S
    J Anal Toxicol; 1998; 22(1):33-9. PubMed ID: 9491966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous analysis of six amphetamines and analogues in hair, blood and urine by LC-ESI-MS/MS. Application to the determination of MDMA after low ecstasy intake.
    Chèze M; Deveaux M; Martin C; Lhermitte M; Pépin G
    Forensic Sci Int; 2007 Aug; 170(2-3):100-4. PubMed ID: 17629643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous determination of amphetamines and amphetamine-derived designer drugs in human urine by GC-MS.
    Maresová V; Chadt J; Prikryl L
    Neuro Endocrinol Lett; 2006 Dec; 27 Suppl 2():121-4. PubMed ID: 17159795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On the metabolism and the toxicological analysis of methylenedioxyphenylalkylamine designer drugs by gas chromatography-mass spectrometry.
    Maurer HH
    Ther Drug Monit; 1996 Aug; 18(4):465-70. PubMed ID: 8857570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The disposition into hair of new designer drugs; methylone, MBDB and methcathinone.
    Kikura-Hanajiri R; Kawamura M; Saisho K; Kodama Y; Goda Y
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Aug; 855(2):121-6. PubMed ID: 17604703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sweat testing in opioid users with a sweat patch.
    Kintz P; Tracqui A; Mangin P; Edel Y
    J Anal Toxicol; 1996 Oct; 20(6):393-7. PubMed ID: 8889674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoassay responses of MBDB.
    Kintz P; Giroud C
    J Anal Toxicol; 1997; 21(7):589-90. PubMed ID: 9399133
    [No Abstract]   [Full Text] [Related]  

  • 18. Simultaneous detection of some drugs of abuse in saliva samples by SPME technique.
    Fucci N; De Giovanni N; Chiarotti M
    Forensic Sci Int; 2003 Jun; 134(1):40-5. PubMed ID: 12842356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of sweat testing for the detection of MDMA after a single-dose administration.
    Pichini S; Navarro M; Pacifici R; Zuccaro P; Ortuño J; Farré M; Roset PN; Segura J; de la Torre R
    J Anal Toxicol; 2003; 27(5):294-303. PubMed ID: 12908943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GC-MS studies on side chain regioisomers related to substituted methylenedioxyphenethylamines: MDEA, MDMMA, and MBDB.
    Awad T; Belal T; Maher HM; DeRuiter J; Clark CR
    J Chromatogr Sci; 2010 Oct; 48(9):726-32. PubMed ID: 20875234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.